BCG005
/ Biocytogen, LiberoThera
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 17, 2022
Biocytogen to Present Progress of Preclinical and Clinical Assets at BIO-EUROPE 2022
(Businesswire)
- "Biocytogen Pharmaceuticals...will present at the upcoming BIO-EUROPE conference in Leipzig, Germany on October 24-26 and virtually on November 2-4, 2022....Dr. Vivian Tian, Sr. Director of Biocytogen Europe Innovation Center (BEIC), will give an oral presentation introducing Biocytogen’s pipeline assets and the progress of Project Integrum, highlighting the progress of several antibody programs, including TNFR2, B7-H3, CCR8, and Siglec-15."
Pipeline update • Oncology
1 to 1
Of
1
Go to page
1